VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
MSMorgan Stanley
$223.17$355.5B
Research
OverviewAnalysisShould I Buy?
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksMSShould I Buy?

Buy or sell guide

MS logo

Should I Buy MS Stock Right Now?

A fast read on Wall Street conviction, live analyst commentary on X, and current valuation context for Morgan Stanley.

Updated 2026-06-21

Wall Street currently rates MS buy with a 12-month price target of $201 (-9.8% downside). The sections below cover the bull case, key risks, and latest earnings context for MS.

Wall Street
Buy52 analysts
Consensus target
$201 target (-9.8%)Current price $223.17
Analyst sentiment
No recent analyst posts capturedWaiting for fresh posts
Earnings context
EPS beat 13.6%Reported Wed Apr 15

Is MS a Buy Right Now?

According to 52 Wall Street analysts, MS is currently rated Buy with a consensus 12-month price target of $201 — implying -9.8% downside from $223.17. Analyst targets range from $187 to $211.

Continue research

Full price target breakdownMS stock analysisEarnings historyPrice historyOverview page

Wall Street verdict

Should I Buy MS Stock? Here's What Analysts Think

52 analysts currently cover MS. Below is their consensus rating, price target range, and implied upside.

According to 52 analysts, Morgan Stanley (MS) is rated Buy with a consensus 12-month price target of $201 — representing 10% downside from today's price of $223. The bull case target is $211, the bear case is $187.

MS logoMS
Buy
From 52 analyst ratings
Current price
$223.17
Consensus Target
$201 (-9.8% downside)
Forward P/E
18.8x
Coverage
52 analyst ratings
High target$211
Low target$187

At $223.17, the consensus setup implies -9.8% versus the 12-month target.

  • 28 of 52 analysts lean Buy or Strong Buy, while 24 stay on Hold and 0 lean bearish.
  • MS trades at roughly 18.8x forward earnings, so the bull case still depends on growth staying strong.
  • Analysts span a wide range from $187 to $211, so conviction matters as much as the consensus target.

Below, compare that institutional answer with the live analyst commentary on X for MS right now.

Why the consensus reads Buy for MS

54%
46%
28 Buy54%24 Hold46%0 Sell0%

Analyst ratings update weekly. Get MS's next verdict in your inbox.

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

1 of 1 analysts raised targetsJP Morgan $187
Jun 2026

Live commentary on X

What Analysts Are Saying About Morgan Stanley Right Now

Real posts from high-reach stock analysts mentioning MS, shown exactly as written. Sorted by engagement — most discussed first.

No recent posts captured

No high-reach analysts have posted about MS in the last 7 days. Check back after the next earnings release or market-moving event.

View analyst price targetsSee earnings history

Should you buy MS?

Is MS a Buy, Hold, or Sell Right Now?

A structured look at the bull case, the risks, and the most recent earnings execution for MS before you decide whether to buy, hold, or sell.

Current setup

MS beat estimates last quarter. Below are the key reasons analysts remain constructive and the risks that could change that view.

Bull Case

What keeps the long thesis intact

  • Strong Financials and GrowthMicrosoft has demonstrated impressive financial performance, with strong operating margins and a significant contracted backlog that has more than doubled in the past year. Analysts project continued double-digit revenue and operating income growth.
  • AI Investments Driving GrowthMicrosoft's AI business has surpassed an annual revenue run rate of $37 billion, with significant year-over-year growth. New AI capacity in late 2026 is expected to reaccelerate Azure cloud growth.
  • Analyst OptimismThe consensus among financial analysts is overwhelmingly bullish, with most rating MSFT as a 'Strong Buy' or 'Buy.' The average price target suggests significant upside potential.
  • Diverse Business SegmentsMicrosoft's diverse product offerings, including Windows, Office, and cloud services, cater to both consumers and enterprise clients, providing a stable foundation for growth.

Wall Street rates MS buy, giving the bull case institutional backing from 52 analysts.

Watch Out For

What can break the setup quickly

  • High CapEx and Margin PressurePlanned AI infrastructure investments of $80 billion to $146 billion for FY2026 could compress free cash flow margins in the near term, growing faster than revenue.
  • Execution Risks and CompetitionPotential execution risks include slower-than-expected enterprise adoption of Microsoft 365 Copilot and intensifying competition in the technology sector.
  • Valuation ConcernsMicrosoft's price-to-earnings (P/E) ratio may suggest the stock is overvalued compared to peers, with some analysts reducing price targets.
  • Monetization ChallengesConcerns exist about Microsoft's ability to effectively monetize AI initiatives like its AI chatbot and persuade enterprises to purchase agentic AI software.

Watch whether new negative commentary on MS points to these structural risks or is simply reacting to short-term price moves.

MS Earnings Reaction — What the Last Quarter Showed

Last Quarter

EPS
$3.43 vs $3.02 est.Beat 13.6%
Revenue
$20.6B vs $19.7B est.Beat 4.3%
Consensus-Based Analysis Tools

Full Stock Analysis

Deep dive into MS consensus models and risk factors.

View Analysis

Should I Buy MS?

Wall Street verdict, signals, and target summaries.

See Verdict

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

MS — Frequently Asked Questions

Quick answers to the most common questions about buying MS stock.

Should I buy MS stock right now?
Verdict

MS faces headwinds — analysts' $201 target is -9.8% from $223.17, suggesting limited near-term upside. This is informational only — verify the data and consider your own risk tolerance before deciding.

Is now a good time to buy MS?
Timing

Timing depends on your horizon, but the data signals are: consensus rating "Buy" with -9.8% upside to the $201 target. In the past 30 days, 1 of 1 covering analysts raised their price targets — a bullish signal.

What is the price target for MS stock?
Price Target

MS's consensus 12-month price target is $201, set by 52 Wall Street analysts. The bull case high is $211 and the bear case low is $187. From the current price of $223.17, this implies -9.8% upside.

Is MS overvalued or undervalued?
Valuation

MS appears overvalued — the $201 consensus target is -9.8% from today's $223.17. It trades at a forward P/E of 18.8x. Targets range from $187 (bear) to $211 (bull), reflecting different assumptions about growth and margins.

Should I buy MS before earnings?
Earnings

MS reports next quarter. Earnings-week moves are volatile — historically, analyst targets revise upward after a beat and downward after a miss. The current consensus is "Buy" with a $201 target. Consider position sizing rather than going all-in pre-print.

What are analysts saying about MS stock?
Coverage

Of 52 analysts covering Morgan Stanley (MS): 0 Strong Buy, 28 Buy, 24 Hold, 0 Sell, 0 Strong Sell — a "Buy" consensus. The 12-month price target is $201 (range $187–$211). Bullish analysts outnumber bearish by more than 2-to-1.

What are the risks of buying MS stock?
Risks

No analyst currently rates MS a Sell, but the 24 Hold ratings reflect concerns about valuation, execution risk, or near-term catalysts. See the Bull vs. Risk cards above for the specific theses on Morgan Stanley.

This page is for informational purposes only and does not constitute financial advice. Always conduct your own research before investing.